Micron Biomedical strengthens its leadership team with a veteran executive from Lilly and AstraZeneca to drive global product development and commercialization efforts.
Appointment of a seasoned drug delivery executive from Lilly and AstraZeneca to lead global product development and commercialization.
Micron Biomedical has tapped a seasoned drug delivery veteran with experience at Eli Lilly and AstraZeneca to spearhead its global product development. This strategic hire marks a pivotal transition for the company as it shifts from a platform technology focus toward commercialization.
The appointment marks a transition for the company as it moves from focusing on platform technology to prioritizing global product development and commercialization.